BDKRB1 and posterior cortical atrophy: Aligned with this objective, we provide supportive evidence that the radiolabeled 64Cu/NOTA-βAla-R954 is a promising dual-purpose agent for both imaging and therapy in subcutaneous PCa mouse model with endogenous B1R expression, eliminating the need for radionuclide substitution.